Whalerock Point Partners, LLC Pfizer Inc Transaction History

Whalerock Point Partners, LLC

$489 Million
Q3 2025

A detailed history of Whalerock Point Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 37,026 shares of PFE stock, worth $928,612. This represents 0.19% of its overall portfolio holdings.

Number of Shares

37,026

Previous 37,026 -0.0%

Holding current value

$928,612

Previous $897,000 5.13%

% of portfolio

0.19%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$21.59 - $24.84 $3,238 - $3,726	-150 Reduced 0.4%	37,026 $897,000
Q1 2025 May 15, 2025	SELL	$25.01 - $27.13 $12,505 - $13,565	-500 Reduced 1.33%	37,176 $942,000
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $99,200 - $120,760	-4,000 Reduced 9.6%	37,676 $999,000
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $1,080 - $1,224	-39 Reduced 0.09%	41,676 $1.21 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $985 - $1,154	39 Added 0.09%	41,715 $1.17 Million

Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $144,336 - $165,744	-5,575 Reduced 11.8%	41,676 $1.16 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $23,726 - $30,817	-908 Reduced 1.89%	47,251 $1.36 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $83,434 - $97,526	-2,600 Reduced 5.12%	48,159 $1.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $9,969 - $11,534	276 Added 0.55%	50,759 $1.86 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $105,959 - $137,943	2,690 Added 5.63%	50,483 $2.06 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $20,165 - $26,323	483 Added 1.02%	47,793 $2.45 Million
Q3 2022 Nov 16, 2022	BUY	$43.76 - $53.42 $1.98 Million - $2.42 Million	45,240 Added 2185.51%	47,310 $2.07 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $1.91 Million - $2.33 Million	-43,595 Reduced 95.47%	2,070 $2.07 Billion
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $2,326 - $2,758	50 Added 0.11%	45,665 $2.39 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $13,725 - $17,007	300 Added 0.66%	45,615 $2.36 Billion
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $34,089 - $50,531	825 Added 1.85%	45,315 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $51,025 - $65,546	1,300 Added 3.01%	44,490 $1.91 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $3,590 - $4,068	-100 Reduced 0.23%	43,190 $1.69 Billion
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $306,433 - $345,595	-9,150 Reduced 17.45%	43,290 $1.57 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $1.7 Million - $2.16 Million	50,660 Added 2846.07%	52,440 $1.93 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1.44 Million - $1.69 Million	-45,310 Reduced 96.22%	1,780 $61,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $952,635 - $1.16 Million	-31,628 Reduced 40.18%	47,090 $1.54 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $5,324 - $7,608	-197 Reduced 0.25%	78,718 $2.57 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $688,324 - $781,160	-20,909 Reduced 20.95%	78,915 $3.09 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $6,920 - $8,973	-213 Reduced 0.21%	99,824 $3.59 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $285,000 - $313,120	7,600 Added 8.22%	100,037 $4.25 Million
Q2 2018 Mar 04, 2019	SELL	$32.98 - $35.16 $305,065 - $325,229	-9,250 Reduced 9.1%	92,437 $3.35 Million
Q1 2018 Apr 05, 2018	SELL	$31.91 - $37.02 $3,191 - $3,702	-100 Reduced 0.1%	101,687 $3.61 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $24,945 - $26,467	-750 Reduced 0.73%	101,787 $3.69 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $3.18 Million - $3.5 Million	102,537	102,537 $3.66 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Account

Whalerock Point Partners, LLC Pfizer Inc Transaction History